de Jong W H, De Boer E C, Van Der Meijden A P, Steerenberg P A, Debruyne F M
Laboratory for Pathology, National Institute of Public Health and Environmental Protection, Bithoven, The Netherlands.
Virchows Arch B Cell Pathol Incl Mol Pathol. 1991;61(3):159-67.
The intravesical administration of bacillus Calmette-Guérin (BCG) is used as an adjuvant therapy after transurethral resection for superficial bladder cancer in man. The aim of this study was to characterize with monoclonal antibodies the cellular infiltrates in the bladder wall occurring after one or two cycles, each comprising six weekly intravesical BCG administrations in guinea pigs. BCG-RIVM and BCG-TICE were instilled once a week in undamaged bladders at weeks 1-6 and 11-16, respectively, and retained in the bladder for 1 h. Autopsy was performed 1 week after the last BCG administration at weeks 7 and 17. By routine histology, a single BCG course induced scattered focal infiltrates consisting of minor to severe accumulations of mononuclear cells. After two cycles of BCG, a much more severe inflammatory reaction sometimes occupying almost the total bladder mucosa was noted. The major component of this inflammation was mononuclear cells, mainly lymphocytes, while typical BCG granulomas were occasionally observed. In general, the epithelial layer of the bladder showed no visible alterations. Immunohistochemical staining showed that the majority of mononuclear cells present in the infiltrate were T-cells. Widely scattered B-cells and macrophages were also present, but were much fewer in number than the T-cells. In general, T-helper/inducer cells were more frequent than T-suppressor/cytotoxic cells. Pseudofollicles, also noted after H&E staining, consisted mainly of B-cells. The second series of BCG administrations produced pseudofollicles in the infiltrates in all animals investigated.(ABSTRACT TRUNCATED AT 250 WORDS)
卡介苗(BCG)膀胱内给药被用作人类浅表性膀胱癌经尿道切除术后的辅助治疗。本研究的目的是用单克隆抗体对豚鼠膀胱壁在一或两个疗程(每个疗程包括每周一次共六次膀胱内注射BCG)后出现的细胞浸润进行特征分析。BCG-RIVM和BCG-TICE分别在第1至6周和第11至16周每周一次注入未受损的膀胱,并在膀胱内保留1小时。在第7周和第17周最后一次注射BCG后1周进行尸检。通过常规组织学检查,一个BCG疗程诱导出散在的局灶性浸润,由单核细胞轻度至重度聚集组成。两个BCG疗程后,观察到更严重的炎症反应,有时几乎占据整个膀胱黏膜。这种炎症的主要成分是单核细胞,主要是淋巴细胞,偶尔可见典型的BCG肉芽肿。一般来说,膀胱上皮层没有明显改变。免疫组织化学染色显示,浸润中存在的大多数单核细胞是T细胞。也存在广泛散在的B细胞和巨噬细胞,但数量比T细胞少得多。一般来说,辅助/诱导性T细胞比抑制/细胞毒性T细胞更常见。苏木精和伊红染色后也观察到的假滤泡主要由B细胞组成。在所有研究的动物中,第二次BCG给药在浸润中产生了假滤泡。(摘要截断于250字)